THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is 72.37.
Share Price | ₹217.8 | May 02,2024 |
Market Cap | ₹2,003.3 Cr | |
Earnings-TTM | ₹27.7 Cr | TTM-Consolidated Results |
Price/Earnings | 72.37x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,003.3 Cr] as on May 02,2024
(/) Earnings [ ₹27.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 72.37x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay 72.37 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 9.35x.
- THEMIS MEDICARE 's operated at median p/e ratio of 8.9x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2023 at 18.87x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2019 of 0x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
THEMIS MEDICARE | 27.68 | 72.37 | 2,003.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.49 | 364,315.0 |
CIPLA LTD | 3,744.03 | 30.61 | 114,614.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 20.14 | 104,900.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 33.66 | 99,426.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 76.09 | 105,233.0 |
MANKIND PHARMA LTD | 1,743.30 | 53.63 | 93,499.3 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 60.57 | 90,493.5 |
LUPIN LTD | 1,809.74 | 41.50 | 75,096.2 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.34 | 67,608.5 |
ABBOTT INDIA LTD | 1,145.58 | 49.35 | 56,532.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.14x |
Max industry PE | 76.09x |
Median industry PE | 41.50x |
Average industry PE | 45.70x |
You may also like the below Video Courses